0001179110-12-008025.txt : 20120508
0001179110-12-008025.hdr.sgml : 20120508
20120508164702
ACCESSION NUMBER: 0001179110-12-008025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120507
FILED AS OF DATE: 20120508
DATE AS OF CHANGE: 20120508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELDMAN MICHEL J
CENTRAL INDEX KEY: 0001236488
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13305
FILM NUMBER: 12822013
MAIL ADDRESS:
STREET 1: 626 HOMEWOOD AVENUE
STREET 2: #107
CITY: HIGHLAND PARK
STATE: IL
ZIP: 60035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884629
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953872914
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 9092701400
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0305
4
2012-05-07
0
0000884629
WATSON PHARMACEUTICALS INC
WPI
0001236488
FELDMAN MICHEL J
626 HOMEWOOD AVENUE
#107
HIGHLAND PARK
IL
60035
1
0
0
0
Common Stock, par value $0.0033
2012-05-07
4
M
0
20000
36.57
A
33177
D
Common Stock, par value $0.0033
2012-05-07
4
S
0
20000
73.77
D
13177
D
Common Stock, par value $0.0033
1000
I
by spouse
Non-Qualified Options to Purchase Common Stock
36.57
2012-05-07
4
M
0
20000
0
D
2006-05-17
2014-05-17
Common Stock, par value $0.0033
20000
10000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.75 to $73.89, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
/s/MICHEL J. FELDMAN
2012-05-08